Originally published by our sister publication Infectious Disease Special Edition
By Gina Shaw
More than half of patients with positive cultures for bloodstream infections achieved optimal therapy within 48 hours using the Biofire Blood Culture Identification 2 (BCID2; bioMérieux) panel, a rapid multiplex polymerase chain reaction–based diagnostic platform, in a single-center retrospective cohort study presented at MAD-ID 2025, in Orlando, Fla.
The study, conducted at Brigham and